Saturday, March 6, 2021
Home Life Style Health & Fitness New Drug That May Increase The Survival of Patients With Bladder Cancer

New Drug That May Increase The Survival of Patients With Bladder Cancer

This new type of drug has led to a survival advantage in bladder cancer which has been difficult to achieve in this difficult disease

Researchers have found that a new type of drug that helps target chemotherapy directly to cancer cells may increase the survival of patients with the most common form of bladder cancer.

According to the results from a phase III clinical trial, the risk of death was 30 per cent lower with the new drug than with chemotherapy in patients with locally advanced or metastatic urothelial cancer.

Please Follow NewsGram on Facebook To Get Latest Updates!

However, the researchers say, the side effects of the drug were manageable and overall similar to chemotherapy. “This new type of drug has led to a survival advantage in bladder cancer which has been difficult to achieve in this difficult disease. It reduced the death rate by 30 per cent and beat chemotherapy in every setting, so this really is a big deal,” said lead author Tom Powles, Professor of Genitourinary Oncology at Queen Mary University of London.

Cancer
Researchers have found that a new type of drug that helps target chemotherapy directly to cancer cells may increase the survival of patients with the most common form of bladder cancer. Unsplash

For the study, published in the New England Journal of Medicine, the team involved 608 patients in 19 countries and tested a new ‘antibody-drug conjugates’ (ADC) drug enfortumab vedotin, in adult patients with locally advanced or metastatic urothelial cancer who were previously treated with platinum-based chemotherapy and an immunotherapy drug, called a PD-1/L1 inhibitor.

The team found that the risk of death was 30 per cent lower with the new drug than with chemotherapy, with a median survival of approximately 13 months for the new drug. Median progression-free survival, which is the time without progression of cancer, was 5.6 months for the new drug vs 3.7 months for chemotherapy.

ALSO READ: AI-Based 5G Integrated Recognition System That Detects Human Emotions

Overall response rate, the percentage of patients with either complete or partial response, was 40.6 per cent versus 17.9 per cent of patients in the chemotherapy arm. Urothelial cancer is the most common type of bladder cancer (90 per cent of cases) and can also be found in the renal pelvis (where urine collects inside the kidney), ureter (the tube that connects the kidneys to the bladder) and urethra. Globally, approximately 549,000 new cases of bladder cancer and 200,000 deaths are reported annually. (IANS)

STAY CONNECTED

19,120FansLike
362FollowersFollow
1,773FollowersFollow

Most Popular

A Gentleman’s Guide With A Detailed Regime For The Amateur To The Pro

While picking the right products can be a daunting task, men are serious about grooming, self-care, and wellness routines. With the changes the world...

Indian Women Feel The Pressure To Seek Permission For Their Professional Choices

Do young Indian women still feel the pressure to seek permission for their professional choices? According to new OkCupid data, an overwhelming 79 percent...

Study: The Market For Luxury Smart Homes And Villas Is Constantly Thriving

As the real estate sector emerges out of pandemic, the market for luxury smart homes and villas in India is thriving and demand has...

Benefits of “Heeng” : The Extraordinary Spice of Every Indian Household!

In every Indian household, the most important kitchen ingredient that is never missed in every Indian household is "Heeng" or Asafoetida. It has a...

Can AI Get Common Sense? Facebook Model Shows The Way

In an advance to building machines with common sense, Facebook researchers have developed a new Artificial Intelligence (AI) model that can learn from any...

WHO: Ban On Vaping Can Be Counterproductive

Millions of vapers across Asia could feel forced to return to smoking if a proposal from the World Health Organization (WHO) on e-cigarettes and...

Study: Smoking Cessation Drug Cytisine May Help Treat Parkinson’s Disease

A smoking cessation drug -- cytisine -- may help treat Parkinson's disease or stop its progression in women, say, researchers, including an Indian-origin. The...

5 Healthy Ingredients To Include In Our Diet To Channelize Our Inner Boss Lady

Women have always been the epicenter of our family lives, and are now budding into entrepreneurs, impactful team players, and opinion leaders that shape...

Recent Comments